Evidence map›Paper›PMID 36998641›Full record

ArticleFrontiers in veterinary science2023

Long-term nutritional management of an obese German Spitz with paroxysmal dyskinesia, calcium oxalate urolithiasis, and suspected pancreatitis-A case report.

Camila Baptista da Silva, Michelle Hermans, Norberto Ruiz-Suárez, Fien Verdoodt, Sofie Fatima Mareyam Bhatti, Myriam Hesta

Open access · goldFull text readCase Reports
In one paragraph

Article in Frontiers in veterinary science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Myotonia Congenita in Australian Merino Sheep with a Missense Variant inAnimals : an open access journal from MDPI · 2024
    Article
  2. Canine paroxysmal dyskinesia-a review.Frontiers in veterinary science · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Camila Baptista da SilvaDepartment of Morphology, Imaging, Orthopaedics, Rehabilitation and Nutrition, Ghent University, Merelbeke, Belgium.
Michelle HermansDepartment of Small Animal, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Norberto Ruiz-SuárezDepartment of Morphology, Imaging, Orthopaedics, Rehabilitation and Nutrition, Ghent University, Merelbeke, Belgium.
Fien VerdoodtDepartment of Morphology, Imaging, Orthopaedics, Rehabilitation and Nutrition, Ghent University, Merelbeke, Belgium.
Sofie Fatima Mareyam BhattiDepartment of Small Animal, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Myriam HestaDepartment of Morphology, Imaging, Orthopaedics, Rehabilitation and Nutrition, Ghent University, Merelbeke, Belgium.
Ghent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To our knowledge, this is the first description of long-term nutritional management in a dog with paroxysmal dyskinesia. Case summary: An obese 9-year-old, male entire, German Spitz was presented for dietary management after being diagnosed with calcium oxalate urolithiasis and suspected pancreatitis. Since he was seven years old, the dog has had a history of neurological signs, which were thought to be epileptic seizures. He was treated with phenobarbital and potassium bromide and was clinically controlled. For his nutritional advice, aiming to minimize one of the most important risk factors for the diseases, a weight loss program was started and successfully executed. However, 10 months later, the dog restarted presenting neurological episodes at a high frequency (3x/week). Based on videos and the characteristics of the neurological signs, the dog was diagnosed with paroxysmal dyskinesia. To investigate the role of gluten intake on this patient's neurological signs, a dietary trial with a commercial hypoallergenic diet (gluten-free; hydrolyzed protein) was followed. During the 3 months of the dietary trial, four neurologic episodes related to food indiscretion occurred. Upon the decrease in neurological episodes, the anti-seizure drugs were slowly discontinued. During this period, the dog presented only two neurologic episodes that were related to the days that the anti-seizure drugs were decreased. For 4 months the dog remained episode-free. However, a change in the dog's diet to another gluten-free diet (higher fat) led the dog to vomit and experience another neurologic episode. Once the dog was back to the previous gluten-free diet, it clinically improved, and no other clinical signs were reported by the client during the next 5 months. Conclusion: Although a relationship between gluten and paroxysmal dyskinesia cannot be confirmed, the dog's improvement after the nutritional management and the removal of the anti-seizure therapy is supportive of dietary association.

Indexed as

bladder stonesdoggastrointestinal signsneurological signsnutrition

Identifiers

PMID36998641
PMCPMC10043185
OpenAlexW4324145458

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read51
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.